Publication | Open Access
Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib
12
Citations
17
References
2022
Year
Ritonavir-boosted ExposureOpen LabelPharmacologyKinase InhibitorsPharmacological IssuePharmacotherapyMedicineAdverse Drug ReactionDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1